EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Benghazi, Benghazi, Libya.
- PharmD, Faculty of Pharmacy, Libyan International Medical University, Benghazi, Libya.
- Cite This Article as
- Corresponding Author
Context: Metformin is the first line treatment in type II diabetes mellitus. In addition, it was used for weight reduction in both diabetic and non-diabetic obese patients.
Aims: The aim of this study was to examine the efficacy of metformin in weight reduction among diabetic and non-diabetic obese patient in Benghazi, Libya.
Settings and Design: a cross-sectional study
Methods and Material: A hundred well-designed a cross-sectional survey was distributed from January to December 2020 and filled by diabetic and non-diabetic obese patients (66 and 34, respectively) in Benghazi city.
Statistical analysis used: SPSS statistics soft wear (Version 21.0 SPSS Inc.: Chicago, IL, USA).
Results: Results had shown that 66.7 % of diabetic obese patients were more than 50 years while 35.5 % of non- diabetic obese patients were 21-25 years. 1-5 kg was the weight reduction in both diabetic and non-diabetic obese patients (43.9 % and 38.2 %, respectively)
Conclusions: According to this study, metformin is an eï¬€ective therapy to reduce weight in diabetic and non-diabetic obese patients. Further studies are needed with exact weight reduction.
[Hanin F. Hussin, Sanad W. Alobidy, Fatma M. Bosafita and Iman E. Mohamed (2021); EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS Int. J. of Adv. Res. 9 (Feb). 893-897] (ISSN 2320-5407). www.journalijar.com
University of benghazi
Libyan Arab Jamahiriya
Article DOI: 10.21474/IJAR01/12531
DOI URL: http://dx.doi.org/10.21474/IJAR01/12531
This work is licensed under a Creative Commons Attribution 4.0 International License.